Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Antigen processing and presentation	5/78	1.7893269725981182e-08	1.467248117530457e-06	109.52054794520548	-282.9342881353233	CD4;CD8A;HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Hematopoietic cell lineage	4/99	4.2131304291399016e-06	0.00017273834759473595	55.95087719298245	-138.0145897139532	CD4;CD8A;HLA-DRB1;TNF
KEGG_2021_Human	Type I diabetes mellitus	3/43	1.6429423914376138e-05	0.00026944255219576866	86.01428571428572	-141.158089869663	HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Graft-versus-host disease	3/42	1.5293149491516165e-05	0.00026944255219576866	88.23076923076923	-143.80928698800247	HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Allograft rejection	3/38	1.1267399953362688e-05	0.00026944255219576866	98.36326530612244	-155.5765022451814	HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Cell adhesion molecules	4/148	2.085580460264673e-05	0.0002850293295695053	36.68518518518518	-97.05310244366827	CD4;CD8A;HLA-A;HLA-DRB1
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.0006714892936203815	55.34101382488479	-100.98537671170521	HLA-DRB1;IL17A;TNF
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	4/219	9.708345438267137e-05	0.0009951054074223815	24.350387596899225	-67.12577033726024	CD4;HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Staphylococcus aureus infection	3/95	0.0001781206903514478	0.001460589660881872	37.15527950310559	-73.03297766135067	C3AR1;C5AR1;HLA-DRB1
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.001460589660881872	37.99047619047619	-74.4091590745228	HLA-DRB1;IL17A;TNF
KEGG_2021_Human	T cell receptor signaling pathway	3/104	0.0002329673917108638	0.0017317445003269245	33.806223479490804	-67.40758155759835	CD4;CD8A;TNF
KEGG_2021_Human	Th17 cell differentiation	3/107	0.0002534260244380865	0.0017317445003269245	32.81868131868132	-65.71442008901244	CD4;HLA-DRB1;IL17A
KEGG_2021_Human	Yersinia infection	3/137	0.0005248515914701949	0.0033106023461966136	25.375266524520256	-52.38188378130509	CD4;CD8A;TNF
KEGG_2021_Human	Asthma	2/31	0.0006292457268839483	0.0036855821146059824	69.30172413793103	-73.992829918215	HLA-DRB1;TNF
KEGG_2021_Human	Primary immunodeficiency	2/38	0.0009469209383415865	0.005176501129600673	55.77777777777778	-62.87407127134141	CD4;CD8A
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.005962571257904333	19.106537530266344	-40.222430877266724	CARD9;HLA-DRB1;TNF
KEGG_2021_Human	Epstein-Barr virus infection	3/202	0.0016236545858167558	0.007831745649233763	16.946877243359655	-35.79178563433967	HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Autoimmune thyroid disease	2/53	0.0018378173017361363	0.0080530060131077	39.299019607843135	-47.75438384041307	HLA-A;HLA-DRB1
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.0080530060131077	16.115516062884485	-34.04865723073064	CD4;HLA-A;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	4/498	0.002222912628244597	0.009006632512525732	10.22132253711201	-27.191293900864785	CARD9;HLA-A;HLA-DRB1;TNF
KEGG_2021_Human	Viral myocarditis	2/60	0.0023497251222600107	0.009006632512525732	34.525862068965516	-42.95708800176444	HLA-A;HLA-DRB1
KEGG_2021_Human	Coronavirus disease	3/232	0.0024164136009215383	0.009006632512525732	14.670617592014972	-30.966105875434415	C3AR1;C5AR1;TNF
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.013693795873383078	26.643333333333334	-34.49723066158141	HLA-DRB1;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.015674983731256763	11.412915851272016	-23.74866982495136	CD4;IL17A;TNF
KEGG_2021_Human	Complement and coagulation cascades	2/85	0.004661598778005346	0.015674983731256763	24.051204819277107	-31.541623523071053	C3AR1;C5AR1
KEGG_2021_Human	Th1 and Th2 cell differentiation	2/92	0.005440715912052039	0.017159180953394894	22.16111111111111	-29.32328202848766	CD4;HLA-DRB1
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.01723111806152376	21.67391304347826	-28.742216935482162	IL17A;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.020225884039629816	19.524509803921568	-26.130280011490946	CARD9;TNF
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.02254450389546043	18.086363636363636	-24.33571316400054	HLA-DRB1;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.029480475162429357	15.385658914728682	-20.853034219946885	HLA-A;TNF
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.030225195345734722	14.915413533834586	-20.230385574789178	HLA-DRB1;TNF
KEGG_2021_Human	Phagosome	2/152	0.014335605230985022	0.03673498840439912	13.196666666666667	-17.909946150058477	HLA-A;HLA-DRB1
KEGG_2021_Human	Influenza A	2/172	0.01812904275363809	0.04504792441813101	11.614705882352942	-15.707848772731996	HLA-DRB1;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	2/181	0.019962543247368986	0.04814495724365461	11.018156424581006	-14.859767863470836	CARD9;TNF
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.07027475092129924	8.794843049327355	-11.607417281005194	HLA-A;TNF
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.1022614687239817	24.790123456790123	-13.876145105511855	TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.12308347331386851	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.12423884849196307	5.880699088145897	-7.115618067766183	HLA-A;TNF
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.12423884849196307	18.962174940898347	-11.032973182262484	HLA-DRB1
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.12423884849196307	18.183673469387756	-10.63265628196324	TNF
KEGG_2021_Human	Neuroactive ligand-receptor interaction	2/341	0.06390297287134222	0.12780594574268445	5.699852507374631	-6.82883638517627	C3AR1;C5AR1
KEGG_2021_Human	Legionellosis	1/57	0.06840002327828267	0.13354290259093282	15.896825396825397	-9.424000900813787	TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.15196895320101697	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.15196895320101697	12.880837359098228	-7.74542097629872	TNF
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.15196895320101697	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Pertussis	1/76	0.09024597396088518	0.16087325793027357	11.841481481481482	-7.141387005986298	TNF
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.17805738212603756	8.592233009708737	-5.152341092635986	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.17805738212603756	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.17805738212603756	8.764576457645765	-5.262086311101535	TNF
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.17805738212603756	8.764576457645765	-5.262086311101535	TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.17805738212603756	9.961298377028713	-6.010407578745034	TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.17805738212603756	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.17805738212603756	10.075757575757576	-6.080768259179883	CD4
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.17805738212603756	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.17805738212603756	8.592233009708737	-5.152341092635986	TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.17805738212603756	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.18126175852965906	8.2668743509865	-4.943743954376122	TNF
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.18432759552827566	7.964964964964965	-4.748494648054986	TNF
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.19178808196114777	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.2003862742331971	7.00352733686067	-4.115510268264927	TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.2143072740496224	6.384863123993559	-3.698840756963446	TNF
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.21504696370542742	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.2207548517978192	5.672401433691756	-3.209640069203435	HLA-A
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.2207548517978192	5.562587904360056	-3.1333425612983894	TNF
KEGG_2021_Human	Hepatitis C	1/157	0.17829930575122027	0.2207548517978192	5.635327635327635	-3.183908163692195	TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.2207548517978192	5.70995670995671	-3.235678410841787	TNF
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.2207548517978192	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Hepatitis B	1/162	0.18347437883820783	0.22124851565783887	5.456866804692892	-3.0596637281364782	TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.25065416801918494	4.657210401891253	-2.4954112144854435	C5AR1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.21491040066934372	0.2517521836412312	4.55787037037037	-2.4244944960200487	HLA-A
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.25279824452171756	4.462585034013605	-2.3563138595912863	TNF
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.25474337382043016	4.326732673267327	-2.2588473265567357	HLA-A
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.25474337382043016	4.283224400871459	-2.2275706216550177	TNF
KEGG_2021_Human	Lipid and atherosclerosis	1/215	0.23655445762047492	0.2621279124983641	4.077881619937695	-2.079575623138921	TNF
KEGG_2021_Human	Shigellosis	1/246	0.26614163456811335	0.2893934449502066	3.547845804988662	-1.6951894904190261	TNF
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.2893934449502066	3.4603806994245243	-1.6315316807371463	HLA-A
KEGG_2021_Human	Salmonella infection	1/249	0.2689494049142217	0.2893934449502066	3.503584229390681	-1.6629804039719844	TNF
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.30599230560514296	3.184640522875817	-1.4307154955453085	TNF
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.3216909392470262	2.9484262419416005	-1.2588658824557653	TNF
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.37824983691977637	2.3584328129782675	-0.8341701676241932	TNF
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.37824983691977637	2.32487922705314	-0.8103995559567543	TNF
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	TNF
